A NOVEL ORAL DOMAIN ANTIBODY TO TUMOUR NECROSIS FACTOR (TNF), ENGINEERED TO BE STABLE TO INTESTINAL PROTEASES, RESULTS IN HIGH CONCENTRATIONS OF ACTIVE COMPOUND DETECTED IN FAECES OF CROHN’S PATIENTS AFTER ORAL DOSING

Jan Robinson  1     Scott Crowe  1     Mike West  1     Tim Carlton  1     Luana Maggiore  1     Gary Whale  1     James Ritter  2     Peter Irving  3     Suhail Nurbhai    
1 VHsquared Ltd,Cambridge,United Kingdom
2 Kings College London,London,United Kingdom
3 Guy´s and St Thomas´ Hospital Dept. of Gastroenter

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing